CoChat

Therapeutic Innovations, Diminishing Returns, and Control Rate Preservation

Open access
Kent, David M. · 2009 · JAMA
Cited by 29

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Many aspects of therapeutics development, not least the exorbitant costs, incentivize risk-averse approaches modeled on previously successful therapies that, coupled with sophisticated strategies for “market differentiation”, might offer the best return on investment for industry, and sometimes also lead to meaningful improvements in public health. Even for these narrowly pragmatic aims, such strategies may have a natural life cycle. The Government Accountability Office on New Drug Development recently summarized empirical evidence for a rising failure rate in phase III clinical testing of new agents15. While other factors surely play a role, declining control rates may be an essential emblem of a broader process of maturation. Assuming theoretical limits on optimal human health and lifespan, the Malthusian relationship between declining control rates, therapeutic benefits and sample size is fundamental and necessarily impacts the marginal efficiency of therapeutic innovation. Though adaptations may preserve control rates permitting innovations that are undoubtedly beneficial, better understanding this relationship may permit wiser allocation of research resources.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2009.1679

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 29

Metadata

Authors
Kent, D. M.
Venue
JAMA
Published
2009-11-25
Volume
302
Issue
20
Pages
2254
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W1995356700
Cited by
29
References
1
FWCI
9.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic Innovations, Diminishing Returns, and Control Rate Preservation. https://app.cochat.ai/papers/10.1001/jama.2009.1679
The paper
Kent, D. M. (2009). Therapeutic Innovations, Diminishing Returns, and Control Rate Preservation. JAMA. https://doi.org/10.1001/jama.2009.1679

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.